Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
As of today, Johnson & Johnson(JNJ) shares are valued at $244.72. The company's market cap stands at 595.63B, with a P/E ratio of 22.07 and a dividend yield of 2.1%.
On 2026-02-15, Johnson & Johnson(JNJ) stock traded between a low of $242.61 and a high of $245.35. Shares are currently priced at $244.72, which is +0.9% above the low and -0.3% below the high.
Johnson & Johnson(JNJ) shares are trading with a volume of 13.27M, against a daily average of 9.11M.
During the past year, Johnson & Johnson(JNJ) stock moved between $141.50 at its lowest and $246.35 at its peak.
During the past year, Johnson & Johnson(JNJ) stock moved between $141.50 at its lowest and $246.35 at its peak.
JNJ News
On Friday, a Pennsylvania state-court jury in Philadelphia ordered Johnson & Johnson (NYSE:JNJ) to pay $250,000 to the family of Gayle Emerson, finding the comp...
Protagonist Therapeutics submitted NDAs for Icotrokinra in plaque psoriasis and Rusfertide in polycythemia vera, advancing two late stage drug candidates. The...
Scientists have identified a genetic cause linked to rare blood clotting events associated with Johnson & Johnson's COVID vaccine. Johnson & Johnson reported e...
Analyst ratings
57%
of 28 ratingsMore JNJ News
Pentair Just Paid Out: Is This Industrial Dividend Built to Last? Quick Read Pentair (PNR) delivered its 50th consecutive annual dividend increase. The 8.0% ra...
Key Points Johnson & Johnson has crushed the market over the past year. The healthcare giant faces some challenges that could harm its results. However, John...
Johnson & Johnson (NYSE:JNJ) on Friday after hours released data from the OMNY-AF pilot study, a prospective, single-arm, multi-center trial. The study pairs t...
Johnson & Johnson (JNJ) is back in focus after reporting better than expected fourth quarter results, setting a US$100b 2026 sales goal, and releasing new OMNY...
Key Points Reliability is one of the most important things about a dividend. Johnson & Johnson is a Dividend King with an attractive yield. Medtronic is two y...